Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

OTOS PTPRO

2.74e-041428239ada235a46f2202c093cf2336de224a5957ed1a
ToppCellfacs-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SOAT2 PTPRO

2.89e-041468226493014daa432db721613ef480d133f3da9eb58
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

OTOS PTPRO

3.13e-0415282bfc7ef4ee26165d18ac4f475a9519e8d52453ba2
ToppCellfrontal_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype

PTPRO EFCAB3

3.13e-0415282f9c29d4568402ca07a717dbffb3ccc7f35c5fe56
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SOAT2 PTPRO

3.17e-0415382c1335e7d7407412431ed4d8c7dfcb2c6086d8483
ToppCellPND07-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

OTOS DNAJC2

3.26e-0415582b5d5c38b269e9318970fcce564df1c8ed7a7ccc6
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SAMD9 EFCAB3

3.92e-041708228fb192b21cdc5a77ba4f276694cff852eb2304b
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SAMD9 EFCAB3

3.92e-0417082239cb4b801b2d71a6facb386f2684c0851504151
ToppCell10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

SOAT2 DNAJC2

4.05e-04173821e4afa020fae682521335b440ccd33c16f37156f
ToppCellBronchial-10x5prime-Immune_Lymphocytic-T-T_CD3|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

SOAT2 TRAV24

5.36e-0419982eb30711ab34510429b644498ecfab4ec3cb61cbc
ToppCellBronchial-10x5prime-Immune_Lymphocytic-T-T_CD3-NKT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

SOAT2 TRAV24

5.36e-041998240f9f771004850be477ee491a7a74c74b84074ab
Drug1,5-AG

SOAT2 ORC2

1.30e-0318272CID000064960
DrugFillalbin [4540-25-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A

SOAT2 PTPRO

1.44e-03192722813_UP
DrugDibucaine [85-79-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A

SOAT2 PTPRO

1.50e-03196721469_UP
DrugGanciclovir [82410-32-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A

SOAT2 SAMD9

1.50e-03196723368_UP
DrugSulfapyridine [144-83-2]; Up 200; 16uM; MCF7; HT_HG-U133A

SOAT2 SAMD9

1.50e-03196726101_UP
DrugAmpyrone [83-07-8]; Up 200; 19.6uM; MCF7; HT_HG-U133A

SOAT2 PTPRO

1.52e-03197722249_UP
DrugEvoxine [522-11-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A

PTPRO SAMD9

1.52e-03197726041_UP
DrugChlorphensin carbamate [886-74-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A

SOAT2 SAMD9

1.52e-03197722279_UP
DrugPancuronium bromide [15500-66-0]; Up 200; 5.4uM; MCF7; HT_HG-U133A

SOAT2 SAMD9

1.54e-03198724393_UP
DrugFenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A

SOAT2 SAMD9

1.54e-03198722269_UP
Drugclozapine; Down 200; 10uM; HL60; HT_HG-U133A

PTPRO SAMD9

1.54e-03198721170_DN
DrugSulfabenzamide [127-71-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A

SOAT2 PTPRO

1.57e-03200722814_UP
Diseaseage-related hearing impairment

DNAJC2 SAMD9

3.22e-0332482EFO_0005782

Protein segments in the cluster

PeptideGeneStartEntry
SFWYNFDSWREFSYL

DNAJC2

216

Q99543
FNSSDYETTSQPYWW

PTPRO

286

Q16827
AMPYWPFSTSDFWNY

OTOS

36

Q8NHW6
FYDTFSTYTWSWNVC

EFCAB3

371

Q8N7B9
FNWLWYETTTYSPYT

ORC2

441

Q13416
WWNFYFSSESYSSPF

SAMD9

691

Q5K651
MFYRDWWNSTSFSNY

SOAT2

376

O75908
WWNSTSFSNYYRTWN

SOAT2

381

O75908
SFPSSNFYALHWYRW

TRAV24

46

A0A0B4J272